CenterBook Partners’s Praxis Precision Medicines PRAX Stock Holding History

CenterBook Partners’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$11.2M	Buy	+38,537	New	+$12.8M	0.51%	41

Other funds holding PRAX

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Kornitzer Capital Management Shawnee Mission, Kansas $4.8B AUM 30.14% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

CenterBook Partners's PRAX Position: Q3 2026 in Review

CenterBook Partners opened a new position in Praxis Precision Medicines (PRAX) in Q3 2026: 38,537 shares worth $11.2M. The stake represents 0.51% of the portfolio and ranks #41 among its holdings.

86 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

CenterBook Partners held 38,537 shares of Praxis Precision Medicines worth $11.2M as of Q3 2026.
Praxis Precision Medicines was a new CenterBook Partners position in Q3 2026.
Praxis Precision Medicines made up 0.51% of CenterBook Partners's portfolio in Q3 2026, its #41 holding.
86 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.